LU87495A1 - Nouveaux derives peptidiques,leur preparation et leur utilisation omme medicaments - Google Patents

Nouveaux derives peptidiques,leur preparation et leur utilisation omme medicaments Download PDF

Info

Publication number
LU87495A1
LU87495A1 LU87495A LU87495A LU87495A1 LU 87495 A1 LU87495 A1 LU 87495A1 LU 87495 A LU87495 A LU 87495A LU 87495 A LU87495 A LU 87495A LU 87495 A1 LU87495 A1 LU 87495A1
Authority
LU
Luxembourg
Prior art keywords
thr
lys
leu
ser
residue
Prior art date
Application number
LU87495A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808275A external-priority patent/GB8808275D0/en
Priority claimed from GB888808528A external-priority patent/GB8808528D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of LU87495A1 publication Critical patent/LU87495A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • C07K9/005—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure containing within the molecule the substructure with m, n > 0 and m+n > 0, A, B, D, E being heteroatoms; X being a bond or a chain, e.g. muramylpeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
LU87495A 1988-04-08 1989-04-07 Nouveaux derives peptidiques,leur preparation et leur utilisation omme medicaments LU87495A1 (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888808275A GB8808275D0 (en) 1988-04-08 1988-04-08 New calcitonin derivatives
GB8808275 1988-04-08
GB888808528A GB8808528D0 (en) 1988-04-12 1988-04-12 Peptide derivatives
GB8808528 1988-04-12

Publications (1)

Publication Number Publication Date
LU87495A1 true LU87495A1 (fr) 1989-11-14

Family

ID=26293749

Family Applications (1)

Application Number Title Priority Date Filing Date
LU87495A LU87495A1 (fr) 1988-04-08 1989-04-07 Nouveaux derives peptidiques,leur preparation et leur utilisation omme medicaments

Country Status (19)

Country Link
US (1) US5541159A (ja)
JP (2) JPH01305099A (ja)
AT (1) ATA900689A (ja)
AU (2) AU3362889A (ja)
BE (1) BE1004357A4 (ja)
CH (1) CH682152A5 (ja)
DK (1) DK163689A (ja)
ES (1) ES2015645A6 (ja)
FR (1) FR2629825B1 (ja)
GB (1) GB2218102B (ja)
IE (1) IE930109L (ja)
IL (1) IL89881A (ja)
IT (1) IT1235894B (ja)
LU (1) LU87495A1 (ja)
MY (1) MY108554A (ja)
NL (1) NL8900864A (ja)
NZ (1) NZ228677A (ja)
SE (1) SE8901241L (ja)
WO (1) WO1989009786A1 (ja)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
DE59100945D1 (de) * 1990-08-04 1994-03-10 Hoechst Ag Gonadoliberin-Antagonisten.
DE4222647A1 (de) * 1991-07-15 1993-01-21 Sandoz Ag Peptid-zubereitungen
EP0632813B1 (en) * 1992-02-13 1999-12-15 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
WO1993016087A2 (en) * 1992-02-13 1993-08-19 Torf Establishment Amadori reaction compounds and products, process for their manufacture, and their use
FR2695391B1 (fr) * 1992-09-04 1994-10-14 Centre Nat Rech Scient Glycopeptides, leur procédé d'obtention, et leurs applications biologiques.
CA2123144A1 (en) * 1993-05-10 1994-11-11 David Bodmer Stabilisation of pharmacologically active compounds in sustained release compositions
WO1994028015A1 (en) * 1993-05-20 1994-12-08 Biotech Australia Pty. Limited Lhrh antagonists
SI9420051A (en) * 1993-08-09 1996-12-31 Biomeasure Inc Chemical modified peptide derivatives, process for their preparation and their use in human therapy
US5698672A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Synthetic calcitonin mimetics
US5698521A (en) * 1995-04-04 1997-12-16 Zymogenetics, Inc. Native calcitonin mimetics
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US6248713B1 (en) 1995-07-11 2001-06-19 Biogen, Inc. Cell adhesion inhibitors
US6239108B1 (en) 1996-07-11 2001-05-29 Biogen, Inc. Cell adhesion inhibitors
US6686350B1 (en) 1996-07-25 2004-02-03 Biogen, Inc. Cell adhesion inhibitors
DE69737769T2 (de) 1996-07-25 2008-05-15 Biogen Idec Ma Inc., Cambridge Molekülmodell für vla-4-inhibitoren
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
JP4372345B2 (ja) 1998-02-13 2009-11-25 アミリン・ファーマシューティカルズ，インコーポレイテッド 新規な混合アミリン活性化合物
NZ509199A (en) 1998-05-28 2003-10-31 Biogen Inc A VLA-4 inhibitor: oMePUPA-V
CZ2002518A3 (cs) 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
DE10024451A1 (de) * 2000-05-18 2001-11-29 Asta Medica Ag Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung
US6875743B1 (en) 2000-11-28 2005-04-05 Biogen, Inc. Cell adhesion inhibitors
US6598784B2 (en) * 2000-12-20 2003-07-29 Meadwestvaco Packaging Syatens, Llc Beverage carton with strap type carrying handle
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
US7196112B2 (en) 2004-07-16 2007-03-27 Biogen Idec Ma Inc. Cell adhesion inhibitors
BRPI0920246A2 (pt) 2008-10-17 2017-06-27 Winconsin Alumni Res Foundation método de preparação de alfa-beta peptídios biologicamente ativos.
GB201813677D0 (en) * 2018-08-22 2018-10-03 Keybioscience Ag Calcitonin mimetics for treating diseases and disorders
TW202320857A (zh) * 2021-07-06 2023-06-01 美商普方生物製藥美國公司 連接子、藥物連接子及其結合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3956260A (en) * 1967-11-09 1976-05-11 Ciba-Geigy Corporation Hypocalcaemic peptides and processes for their manufacture
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4650854A (en) * 1985-06-06 1987-03-17 Usv Pharmaceutical Corporation Amide analogs of calcitonin
HUT44794A (en) * 1985-12-04 1988-04-28 Sandoz Ag Process for production of calcitonine-derivatives and medical preparatives containing such compounds
DE3634435A1 (de) * 1986-10-09 1988-04-14 Hoechst Ag Analoga von gonadoliberin mit verbesserter loeslichkeit, verfahren zu deren herstellung, diese enthaltende mittel und ihre verwendung
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
DK163689A (da) * 1988-04-08 1989-10-30 Sandoz Ag Peptidderivater

Also Published As

Publication number Publication date
GB2218102B (en) 1992-09-16
AU3362889A (en) 1989-11-03
US5541159A (en) 1996-07-30
ATA900689A (de) 1997-01-15
DK163689A (da) 1989-10-30
CH682152A5 (ja) 1993-07-30
IT1235894B (it) 1992-11-23
IL89881A (en) 1994-05-30
FR2629825B1 (fr) 1993-05-14
JPH01305099A (ja) 1989-12-08
NL8900864A (nl) 1989-11-01
GB8907652D0 (en) 1989-05-17
SE8901241D0 (sv) 1989-04-07
GB2218102A (en) 1989-11-08
BE1004357A4 (fr) 1992-11-10
FR2629825A1 (fr) 1989-10-13
IT8947823A0 (it) 1989-04-07
IL89881A0 (en) 1989-12-15
JPH0789994A (ja) 1995-04-04
NZ228677A (en) 1994-08-26
AU3263789A (en) 1989-10-12
DK163689D0 (da) 1989-04-05
SE8901241L (sv) 1990-02-02
IE930109L (en) 1989-10-08
WO1989009786A1 (en) 1989-10-19
MY108554A (en) 1996-10-31
ES2015645A6 (es) 1990-09-01
AU623385B2 (en) 1992-05-14

Similar Documents

Publication Publication Date Title
LU87495A1 (fr) Nouveaux derives peptidiques,leur preparation et leur utilisation omme medicaments
BE1003752A4 (fr) Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments.
JP3266311B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
EP0309297B1 (en) Therapeutic peptides
FI120095B (fi) Menetelmä peptidien valmistamiseksi, joilla on kasvuhormonia vapauttavaa aktiivisuutta
US4410512A (en) Combinations having synergistic pituitary growth hormone releasing activity
FI104252B (fi) Menetelmä terapeuttisesti käyttökelpoisten peptidien kemialliseksi syntetisoimiseksi kiinteässä faasissa
EP0083864B1 (en) Synthetic peptides having pituitary growth hormone releasing activity
HU196227B (en) Process for producing new cyclic vasopressin antagonist peptides and pharmaceutics comprising the same
BG107020A (bg) Кахалалидни съединения
CA1268898A (en) Growth hormone-releasing peptides and method of treating mammals therewith
JPH0219397A (ja) アルギニンバソプレシン拮抗剤の新規線形誘導体類
CA2069943A1 (en) Synthetic calcitonin peptides
HUT50487A (en) Process for production of peptides
JP3178835B2 (ja) 新規ポリペプチドおよびこれを用いる抗ｈｉｖ剤
JP2001500845A (ja) 骨粗鬆症の治寮のための副甲状腺ホルモン類似体
JPS61191698A (ja) 新規な環状ヘキサペプチドｌｈｒｈ拮抗剤
LV10108B (en) Inhibitors of cells proliferation, pharmaceutical composition, process of producing of compounds, methods of inhibition of cellular proliferation
KR100360975B1 (ko) 위장운동자극활성을가지는폴리펩티드
CA1335622C (en) Bradykinin analogs containing a non-peptide bond
FR2682680A1 (fr) Derives peptidiques d'antagonistes de la lr-rh, leur preparation et leur utilisation comme medicaments.
JP2678993B2 (ja) 新規なアルキル化された成長ホルモン放出ペプチド及びそれにより哺乳動物を処理する方法
CA2085603A1 (en) Derivatives of pituitary posterior lobe hormones
OA10136A (fr) Dérivés de la sorbine procédé pour la synthèse de ces peptides et compositions pharmaceutiques les contenant
CA2163114A1 (en) Peptides exhibiting oxytocin antagonistic activity